S100A12 and gastric carcinoma: S100A12 is dysregulated in many types of cancers, upregulated in colorectal cancer and papillary thyroid cancer but reduced in gastric carcinoma and oropharyngeal squamous cells (Thierolf et al., 2008; Funk et al., 2015; Li et al., 2016; Wang et al., 2020).